AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 11012052 — intervention group
Group type: EXPERIMENTAL
Intervention: Interspace cage placement (one-level)
Number of subjects: 54
Study 11012052 — intervention group
Group type: EXPERIMENTAL
Intervention: Interspace cage placement (one or both levels)
Number of subjects: 54
Study 8672383 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% ropivacaine
Number of subjects: 104
Study 8672383 — intervention group
Group type: COMPARATOR
Intervention: 0.25% bupivacaine
Number of subjects: 104
Study 1523568 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient treatment
Number of subjects: 325
Study 1523568 — intervention group
Group type: COMPARATOR
Intervention: Hospital treatment
Number of subjects: 325
Study 6489697 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurocholate (10 mM) at pH 1.1
Number of subjects: 5
Study 6489697 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurocholate (10 mM) at pH 7.0
Number of subjects: 5
Study 6489697 — intervention group
Group type: COMPARATOR
Intervention: Citrate buffer alone
Number of subjects: 5
Study 6489697 — intervention group
Group type: COMPARATOR
Intervention: HCl control solution (200 ml of 100 mM HCl)
Number of subjects: 5
Study 31733767 — intervention group
Group type: EXPERIMENTAL
Intervention: High velocity low amplitude manipulation of the TLJ
Number of subjects: 21
Study 31733767 — intervention group
Group type: COMPARATOR
Intervention: Sham (basic touch)
Number of subjects: 21
Study 31733767 — intervention group
Group type: COMPARATOR
Intervention: Control (laying supine on a plinth)
Number of subjects: 21
Study 29972001 — intervention group
Group type: EXPERIMENTAL
Intervention: RT and intradermal needling (group A)
Number of subjects: 120
Study 29972001 — intervention group
Group type: EXPERIMENTAL
Intervention: RT and acupuncture (group B)
Number of subjects: 120
Study 29972001 — intervention group
Group type: COMPARATOR
Intervention: RT alone (group C)
Number of subjects: 120
Study 27833919 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised walking exercises on the treadmill (n = 24)
Number of subjects: 50
Study 27833919 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercises of lower limbs (n = 26)
Number of subjects: 50
Study 24535349 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-step etch-and-rinse adhesive α
Number of subjects: 50
Study 24535349 — intervention group
Group type: COMPARATOR
Intervention: One-step self-etch adhesive β
Number of subjects: 50
Study 24535349 — intervention group
Group type: EXPERIMENTAL
Intervention: Both adhesives
Number of subjects: 50
Study 22682750 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 months of neo-adjuvant androgen deprivation (NAD) before radiation therapy (RT)
Number of subjects: 276
Study 22682750 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 months of neo-adjuvant androgen deprivation (NAD) before radiation therapy (RT)
Number of subjects: 276
Study 22682750 — intervention group
Group type: COMPARATOR
Intervention: Neo-adjuvant androgen deprivation (NAD) in addition to radiation therapy
Number of subjects: 276
Study 20302872 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based stressor task
Number of subjects: 145
Study 20302872 — intervention group
Group type: EXPERIMENTAL
Intervention: Social rejection stressor task
Number of subjects: 145
Study 20302872 — intervention group
Group type: COMPARATOR
Intervention: Control group (low psychopathic traits)
Number of subjects: 145
Study 18569687 — intervention group
Group type: EXPERIMENTAL
Intervention: Performed actions
Number of subjects: 0
Study 18569687 — intervention group
Group type: EXPERIMENTAL
Intervention: Observed actions
Number of subjects: 0
Study 16048922 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin orally at 10 mg/kg of body weight and streptomycin intramuscularly at 15 mg/kg of body weight daily for 2 weeks
Number of subjects: 10
Study 16048922 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin and streptomycin for 4 weeks
Number of subjects: 10
Study 16048922 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin and streptomycin for 8 weeks
Number of subjects: 10
Study 16048922 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin and streptomycin for 12 weeks
Number of subjects: 10
Study 16048922 — intervention group
Group type: COMPARATOR
Intervention: No antibiotic treatment
Number of subjects: 10
Study 11350535 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimization allocation method
Number of subjects: 0
Study 11350535 — intervention group
Group type: COMPARATOR
Intervention: Conventional analysis following minimization
Number of subjects: 0
Study 9782811 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback/relaxation training
Number of subjects: 119
Study 9782811 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 119
Study 9782811 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment
Number of subjects: 119
Study 9782811 — intervention group
Group type: COMPARATOR
Intervention: Educational/attention control program
Number of subjects: 119
Study 7846337 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous hydrocortisone (500 mg)
Number of subjects: 98
Study 7846337 — intervention group
Group type: COMPARATOR
Intervention: Intravenous normal saline (control)
Number of subjects: 98
Study 3072420 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg captopril once daily
Number of subjects: 15
Study 3072420 — intervention group
Group type: EXPERIMENTAL
Intervention: 37.5 mg captopril twice daily
Number of subjects: 15
Study 3072420 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg captopril three times daily
Number of subjects: 15
Study 3072420 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 30967405 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTonPain guided
Number of subjects: 302
Study 30967405 — intervention group
Group type: EXPERIMENTAL
Intervention: ACTonPain unguided
Number of subjects: 302
Study 30967405 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 302
Study 27222939 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose computed tomography (LDCT)
Number of subjects: 3640
Study 27222939 — intervention group
Group type: COMPARATOR
Intervention: Control arm
Number of subjects: 3640
Study 24978931 — intervention group
Group type: EXPERIMENTAL
Intervention: Foam rubber exercise group (n = 32)
Number of subjects: 93
Study 24978931 — intervention group
Group type: EXPERIMENTAL
Intervention: Stable surface exercise group (n = 31)
Number of subjects: 93
Study 24978931 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 30)
Number of subjects: 93
Study 23712073 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Restructuring and Imagery Modification (CRIM)
Number of subjects: 34
Study 23712073 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (WL)
Number of subjects: 34
Study 21354935 — intervention group
Group type: EXPERIMENTAL
Intervention: Pelvic methotrexate (MTX) injection via the posterior fornix + mifepristone + traditional Chinese medicine
Number of subjects: 96
Study 21354935 — intervention group
Group type: COMPARATOR
Intervention: Intramuscular MTX injection + mifepristone + traditional Chinese medicine
Number of subjects: 96
Study 21354935 — intervention group
Group type: COMPARATOR
Intervention: Mifepristone + traditional Chinese medicine
Number of subjects: 96
Study 19365399 — intervention group
Group type: EXPERIMENTAL
Intervention: escitalopram (serotonin reuptake inhibitor)
Number of subjects: 760
Study 19365399 — intervention group
Group type: EXPERIMENTAL
Intervention: nortriptyline (norepinephrine reuptake inhibitor)
Number of subjects: 760
Study 19365399 — intervention group
Group type: EXPERIMENTAL
Intervention: both escitalopram and nortriptyline
Number of subjects: 760
Study 17455472 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenfu injection (SF)
Number of subjects: 150
Study 17455472 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 150
Study 15198887 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare professionals' awareness of ADR reporting
Number of subjects: 1653
Study 15198887 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare professionals' understanding of ADRs
Number of subjects: 1653
Study 15198887 — intervention group
Group type: EXPERIMENTAL
Intervention: Actual reporting of ADRs
Number of subjects: 1653
Study 15198887 — intervention group
Group type: EXPERIMENTAL
Intervention: Reporting channels used by healthcare professionals
Number of subjects: 1653
Study 15198887 — intervention group
Group type: EXPERIMENTAL
Intervention: Reasons for not reporting ADRs
Number of subjects: 1653
Study 11482924 — intervention group
Group type: EXPERIMENTAL
Intervention: Sotalol (80 mg b.i.d.)
Number of subjects: 128
Study 11482924 — intervention group
Group type: COMPARATOR
Intervention: Bisoprolol (5 mg x day(‐1))
Number of subjects: 128
Study 9757602 — intervention group
Group type: EXPERIMENTAL
Intervention: High-salt diet (21.0 g NaCl)
Number of subjects: 6
Study 9757602 — intervention group
Group type: COMPARATOR
Intervention: Normal-salt diet (approximately 5.6 g NaCl)
Number of subjects: 6
Study 7831452 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel nonsedating compound (dose not specified)
Number of subjects: 177
Study 7831452 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple-rater procedure (MRP)
Number of subjects: 177
Study 7831452 — intervention group
Group type: COMPARATOR
Intervention: Single-rater procedure (SRP)
Number of subjects: 177
Study 7831452 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study 3242576 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive drugs (ACE inhibitors, calcium antagonists, direct vasodilators, alpha‐adrenoceptor blocker, beta‐adrenoceptor blocker)
Number of subjects: 255
Study 3242576 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive agents (four types)
Number of subjects: 255
Study 3242576 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 255
Study 30263038 — intervention group
Group type: EXPERIMENTAL
Intervention: Green cardamom (GC) - 2 capsules of 500 mg three times per day for 3 months
Number of subjects: 87
Study 30263038 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study 27353989 — intervention group
Group type: EXPERIMENTAL
Intervention: Proprioceptive Neuromuscular Facilitation (PNF) techniques
Number of subjects: 63
Study 27353989 — intervention group
Group type: COMPARATOR
Intervention: Traditional Prosthetic Strength Training (TPT)
Number of subjects: 63
Study 24325269 — intervention group
Group type: EXPERIMENTAL
Intervention: CS2 (second conditioning stimulus)
Number of subjects: 19
Study 24325269 — intervention group
Group type: EXPERIMENTAL
Intervention: CS1 (first conditioning stimulus)
Number of subjects: 19
Study 24325269 — intervention group
Group type: EXPERIMENTAL
Intervention: CS1 and CS2
Number of subjects: 19
Study 23814179 — intervention group
Group type: EXPERIMENTAL
Intervention: Fitwits intervention (training for physicians)
Number of subjects: 86
Study 23814179 — intervention group
Group type: COMPARATOR
Intervention: Control group (no Fitwits training)
Number of subjects: 86
Study 20523304 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet group (n = 34)
Number of subjects: 65
Study 20523304 — intervention group
Group type: COMPARATOR
Intervention: Information only control group (n = 31)
Number of subjects: 65
Study 20523304 — intervention group
Group type: EXPERIMENTAL
Intervention: Internet group compliers
Number of subjects: 65
Study 20523304 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 65
Study 20523304 — intervention group
Group type: EXPERIMENTAL
Intervention: Per-protocol analysis
Number of subjects: 65
Study 19401661 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 8 mg intravenously after induction of anaesthesia
Number of subjects: 30
Study 19401661 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline
Number of subjects: 30
Study 16125823 — intervention group
Group type: EXPERIMENTAL
Intervention: Cerebrospinal fluid (CSF) markers for amyloid beta deposits and tau pathology
Number of subjects: 0
Study 16125823 — intervention group
Group type: EXPERIMENTAL
Intervention: Longitudinal hippocampal volume measurements
Number of subjects: 0
Study 16125823 — intervention group
Group type: EXPERIMENTAL
Intervention: CSF levels of hyperphosphorylated tau and isoprostane
Number of subjects: 0
Study 16125823 — intervention group
Group type: COMPARATOR
Intervention: Memory measures and MRI-hippocampal volume evaluations
Number of subjects: 0
Study 15590252 — intervention group
Group type: EXPERIMENTAL
Intervention: Alfentanil (1 mg)
Number of subjects: 175
Study 15590252 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.01 mg
Number of subjects: 175
Study 15590252 — intervention group
Group type: EXPERIMENTAL
Intervention: Remifentanil 0.02 mg
Number of subjects: 175
Study 15590252 — intervention group
Group type: COMPARATOR
Intervention: Saline
Number of subjects: 175
Study 11713062 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial trabeculectomy
Number of subjects: 607
Study 11713062 — intervention group
Group type: COMPARATOR
Intervention: Initial medical therapy
Number of subjects: 607
Study 11713062 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups
Number of subjects: 607
Study 11713062 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical patients
Number of subjects: 607
Study 7490173 — intervention group
Group type: EXPERIMENTAL
Intervention: ST200 at 1 g/die
Number of subjects: 94
Study 7490173 — intervention group
Group type: COMPARATOR
Intervention: ST200 at 0.5 g/die
Number of subjects: 94
Study 7490173 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 94
Study 2208182 — intervention group
Group type: EXPERIMENTAL
Intervention: CQA 206‐291 (5‐30 mg/day)
Number of subjects: 72
Study 2208182 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 517068 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline
Number of subjects: 0
Study 517068 — intervention group
Group type: COMPARATOR
Intervention: Other marketed bronchodilators (clenbuterol, epinephrine, fenoterol, hexoprenaline, isoprenaline, metaproterenol, reproterol, salbutamol)
Number of subjects: 0
Study 517068 — intervention group
Group type: EXPERIMENTAL
Intervention: Terbutaline and other adrenoceptor agonists
Number of subjects: 0
Study 517068 — intervention group
Group type: COMPARATOR
Intervention: Vagolytics (atropine, ipratropium bromide, AA 28‐263)
Number of subjects: 0
Study 517068 — intervention group
Group type: COMPARATOR
Intervention: Theophylline ethylenediamine
Number of subjects: 0
Study 517068 — intervention group
Group type: COMPARATOR
Intervention: Combined substance drug
Number of subjects: 0
Study 31155655 — intervention group
Group type: EXPERIMENTAL
Intervention: Smartphone-assisted counselling application
Number of subjects: 0
Study 31155655 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 28114587 — intervention group
Group type: COMPARATOR
Intervention: Transcorneal electrical stimulation (TES) at 200% of individual electrical phosphene threshold (EPT)
Number of subjects: 52
Study 28114587 — intervention group
Group type: COMPARATOR
Intervention: Transcorneal electrical stimulation (TES) at 150% of individual electrical phosphene threshold (EPT)
Number of subjects: 52
Study 28114587 — intervention group
Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 52
Study 25669730 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltoprazine 5 mg
Number of subjects: 22
Study 25669730 — intervention group
Group type: EXPERIMENTAL
Intervention: Eltoprazine 7.5 mg
Number of subjects: 22
Study 25669730 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 24860934 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance training
Number of subjects: 28
Study 22424441 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (1.0 mg)
Number of subjects: 83
Study 22424441 — intervention group
Group type: COMPARATOR
Intervention: Control group (healthy controls, n=33)
Number of subjects: 83
Study 21058203 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat diet counseling
Number of subjects: 40
Study 21058203 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced carbohydrate diet counseling
Number of subjects: 40
Study 17620068 — intervention group
Group type: COMPARATOR
Intervention: Placebo challenge
Number of subjects: 105
Study 17620068 — intervention group
Group type: EXPERIMENTAL
Intervention: Active food challenge
Number of subjects: 105
Study 17620068 — intervention group
Group type: EXPERIMENTAL
Intervention: Statistical model
Number of subjects: 105
Study 15677734 — intervention group
Group type: EXPERIMENTAL
Intervention: Recombinant human TNF-alpha (n = 8)
Number of subjects: 20
Study 15677734 — intervention group
Group type: COMPARATOR
Intervention: Recombinant human IL-6 (n = 6)
Number of subjects: 20
Study 15677734 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (n = 6)
Number of subjects: 20
Study 12010887 — intervention group
Group type: EXPERIMENTAL
Intervention: Biennial Haemoccult (FOB) test kit
Number of subjects: 152850
Study 12010887 — intervention group
Group type: COMPARATOR
Intervention: Control group (no screening)
Number of subjects: 152850
Study 12010887 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening acceptance
Number of subjects: 152850
Study 10452229 — intervention group
Group type: EXPERIMENTAL
Intervention: L-arginine
Number of subjects: 23
Study 10452229 — intervention group
Group type: COMPARATOR
Intervention: Glycine (placebo)
Number of subjects: 23
Study 8690814 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg ondansetron (oral and intravenous)
Number of subjects: 12
Study 1947367 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefaclor (500 mg tds) for 7 days
Number of subjects: 51
Study 1947367 — intervention group
Group type: COMPARATOR
Intervention: Amoxycillin (500 mg tds) for 7 days
Number of subjects: 51
Study 6361318 — intervention group
Group type: EXPERIMENTAL
Intervention: KS-R1 (ampicillin rectal suppository) at a dose of 125 mg X 4/day for 7 days
Number of subjects: 166
Study 6361318 — intervention group
Group type: COMPARATOR
Intervention: Oral form of ampicillin (ABPC) at the same dosage of 125 mg X 4/day for 7 days
Number of subjects: 166
Study 6361318 — intervention group
Group type: EXPERIMENTAL
Intervention: KS-R1 (ampicillin rectal suppository)
Number of subjects: 166
Study 6361318 — intervention group
Group type: COMPARATOR
Intervention: Oral form of ampicillin (ABPC)
Number of subjects: 166
Study 30945979 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-Port Laparoscopic Appendectomy (SPLA)
Number of subjects: 50
Study 30945979 — intervention group
Group type: COMPARATOR
Intervention: Three-Port Laparoscopic Appendectomy (3PLA)
Number of subjects: 50
Study 30945979 — intervention group
Group type: COMPARATOR
Intervention: Comparison of both interventions
Number of subjects: 50
Study 28986670 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythropoietin (EPO) administered intravenously for three consecutive days
Number of subjects: 100
Study 28986670 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylprednisolone administered intravenously for three consecutive days
Number of subjects: 100
Study 28986670 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation (no treatment)
Number of subjects: 100
Study 28986670 — intervention group
Group type: COMPARATOR
Intervention: Late treatment (>3 days)
Number of subjects: 100
Study 28986670 — intervention group
Group type: COMPARATOR
Intervention: Initial BCVA of no light perception (NLP)
Number of subjects: 100
Study 27003141 — intervention group
Group type: EXPERIMENTAL
Intervention: Group IPT adapted for perinatal loss
Number of subjects: 50
Study 27003141 — intervention group
Group type: COMPARATOR
Intervention: Coping with Depression (CWD)
Number of subjects: 50
Study 24625546 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS treatment
Number of subjects: 10
Study 24625546 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS treatment
Number of subjects: 10
Study 22367073 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct fed microbial (DFMD; 0.3%)
Number of subjects: 192
Study 22367073 — intervention group
Group type: COMPARATOR
Intervention: Standard control starter diet (CSD)
Number of subjects: 192
Study 19169442 — intervention group
Group type: EXPERIMENTAL
Intervention: 5% sodium hypochlorite applied for 1 minute after acid conditioning of tooth surfaces
Number of subjects: 4
Study 19169442 — intervention group
Group type: COMPARATOR
Intervention: Control group (teeth on the left side of the jaw)
Number of subjects: 4
Study 17505047 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-regulation, telephone counseling intervention
Number of subjects: 808
Study 15102866 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 1000 mg
Number of subjects: 0
Study 15102866 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin 1500 mg
Number of subjects: 0
Study 15102866 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (various doses)
Number of subjects: 0
Study 15102866 — intervention group
Group type: EXPERIMENTAL
Intervention: Levofloxacin (1500 mg)
Number of subjects: 0
Study 15102866 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 12066701 — intervention group
Group type: EXPERIMENTAL
Intervention: Excite dual‐cured bonding agent self‐activated by an experimental microbrush in combination with MultiLink resin cement
Number of subjects: 30
Study 12066701 — intervention group
Group type: COMPARATOR
Intervention: Excite light‐cured bonding agent in combination with Variolink II resin cement
Number of subjects: 30
Study 12066701 — intervention group
Group type: COMPARATOR
Intervention: One‐step bonding system in combination with Dual Link resin cement
Number of subjects: 30
Study 9836021 — intervention group
Group type: EXPERIMENTAL
Intervention: d-amphetamine (0.25 mg/kg)
Number of subjects: 11
Study 9836021 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 9860471 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-care laparoscopic cholecystectomy
Number of subjects: 80
Study 9860471 — intervention group
Group type: COMPARATOR
Intervention: Clinical observation after laparoscopic cholecystectomy
Number of subjects: 80
Study 9860471 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 9860471 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-care group
Number of subjects: 80
Study 9860471 — intervention group
Group type: COMPARATOR
Intervention: Clinical observation group
Number of subjects: 80
Study 9860471 — intervention group
Group type: EXPERIMENTAL
Intervention: Day-care patients
Number of subjects: 80